The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Optimization of immunotherapy duration for advanced melanoma: The prospective OTIMAS trial.
 
Milena Mak
Honoraria - Bristol-Myers Squibb; Johnson & Johnson/Janssen; Lilly; Merck KGaA; Sanofi; United Medical
Travel, Accommodations, Expenses - Knight Pharmaceuticals
 
Alice Morais
Travel, Accommodations, Expenses - BMS Brazil
 
Olavo Feher
(OPTIONAL) Uncompensated Relationships - Bayer
 
Abna Vieira
Honoraria - Janssen Oncology (I); MSD Oncology; Novartis; Roche (I)
Consulting or Advisory Role - Novartis
Speakers' Bureau - BMS Brazil; Daiichi Sankyo/Lilly; MSD Oncology
Research Funding - BMS Brazil (Inst); MSD (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo/Lilly
 
Fernanda Alves Oliveira
No Relationships to Disclose
 
Marcelo Queiroz
No Relationships to Disclose
 
Gustavo Albuquerque
No Relationships to Disclose
 
Camila Moniz
No Relationships to Disclose
 
Rossana Lopez
No Relationships to Disclose
 
Luciana Nogueira de Sousa Andrade
No Relationships to Disclose
 
Raphaela Assunção
No Relationships to Disclose
 
Alessandro Gonçalves Campolina
No Relationships to Disclose
 
Tiago Takahashi
No Relationships to Disclose
 
Roger Chammas
No Relationships to Disclose
 
Paulo Hoff
No Relationships to Disclose